BrokeIt - Money Daily · All episodes: ↗

OpenAI in travel, NY AI law, drug development AI

2026-11-11 · 6 min

Listen · Apple Podcasts Listen · Spotify

Stories covered

Transcript

Intro

Priya: So now your travel agent is a large language model.

Theo: I'm Theo.

Priya: And I'm Priya.

Theo: And this is Money Daily for Wednesday, November 11th, 2026. We're talking about your money, and the wild future it's paying for.

Priya: First up, the AI that's planning your next vacation... whether you asked it to or not.

Theo: Plus, New York is rolling out some of the country's toughest new rules for AI developers.

Priya: We'll see how tough they really are.

Theo: And: a new venture fund is betting millions that AI is the key to creating life-saving drugs.

OpenAI acquires Odessia, travel startup created by Sonder founder

Theo: Alright, let's start with OpenAI. They just made a very interesting acquisition.

Priya: They bought a startup called Odessia. Ever heard of it?

Theo: Can't say I have. What's their game?

Priya: It's a travel startup, founded by Francis Davidson—you might know him as the founder of Sonder, the short-term rental company.

Theo: Wait— a travel startup? So the ChatGPT people are getting into... booking flights and hotels?

Priya: That seems to be the plan. OpenAI is being cagey about the details, which… figures.

Theo: But think of the possibilities, Priya! An AI that can plan your entire trip from one sentence. 'Plan me a relaxing, ten-day foodie tour of northern Italy, budget is five thousand dollars.' Done.

Priya: Or, 'Find the cheapest, most miserable multi-leg flight to Columbus, Ohio for a work conference.' I can see the appeal. But what's the business model?

Theo: Convenience! Seamless integration! They could build the ultimate personalized travel concierge.

Priya: Or they could just be buying a team and a pile of user data. A 'concierge' that knows your budget, your travel habits, your preferences... and can sell that profile to the highest bidder.

Theo: That's so cynical. This could take all the hassle out of planning. No more twenty open tabs comparing reviews.

Priya: The bottom line? Sure, planning your vacation might get easier. But it also means one of the world's most powerful AI companies gets a direct line to your wallet and travel habits. Read the terms of service. Carefully.

OpenAI, Anthropic face new oversight as New York’s AI safety law takes effect

Priya: So while OpenAI is out there expanding, New York State is trying to rein it in.

Theo: Right, a big new AI safety law is taking effect. What does it actually do?

Priya: It requires major developers—think OpenAI, Anthropic, the big guys—to register with the state and disclose their safety testing and any 'critical incidents.'

Theo: That sounds... reasonable? Transparency seems like a good thing when you're building world-changing technology.

Priya: Reasonable on paper. But it comes with penalties for non-compliance. Fines.

Theo: Well, yeah. A law needs teeth.

Priya: Sure, but for a company worth tens or hundreds of billions, a fine is just a line item in the budget. It's the cost of doing business, not a deterrent.

Theo: I disagree. It sets a precedent. And it's not just about fines, it's public reporting. Bad press from a 'critical incident' could be way more damaging than writing a check.

Priya: Maybe. Or it just creates a cottage industry for lawyers who write disclosure reports that say a whole lot of nothing. The real risk is it stifles smaller companies who can't afford the compliance department.

Theo: So for the rest of us, it means the AI tools we use might be held to a slightly higher standard, at least in New York. It’s a first step toward accountability.

Priya: And for developers, it means more paperwork. We'll see if it leads to safer AI or just more lawyers.

Proximal Ventures raises debut fund to back startups bringing AI to drug development

Theo: Next up, AI is moving on from vacation plans... to creating new medicines.

Priya: A new venture capital fund just launched. It's called Proximal Ventures.

Theo: And they're backing startups that use AI for drug development, with a debut fund of twenty-seven and a half million dollars.

Priya: Let's put that number in perspective. Twenty-seven-point-five million.

Theo: That's a lot of money!

Priya: It is. But in the world of pharma research, where bringing a single drug to market can cost over a billion dollars? It's a rounding error.

Theo: But it's a debut fund from Sahir Raoof, who used to be at SignalFire. This is seed money! The point is finding promising ideas at the very beginning and giving them a shot.

Priya: The idea is that AI can model molecules and predict drug interactions way faster than a human lab ever could, cutting down that billion-dollar price tag.

Theo: Exactly! This is how you accelerate breakthroughs. Cure diseases faster. That's an incredible return on investment.

Priya: It's a high-risk gamble. That’s the VC model. And for you, it means... waiting. The timeline from seed funding to a drug on your pharmacy shelf is a decade, maybe more. If it even happens at all.

Theo: But it's a bet worth taking. The future of medicine could be growing in this very fund.

Theo: Alright, so to recap: OpenAI is now in the travel business, for better or worse.

Priya: New York is trying, and I stress trying, to put a leash on AI.

Theo: And a new VC fund is betting that AI can discover the next generation of medicine.

Theo: And before we go, a quick note that today, November 11th, is Veterans Day here in the U.S.

Priya: Many businesses, big and small, offer discounts and deals for veterans and active-duty service members. It's always worth asking.

Theo: A small thank you from the business community for an incredible service. That's our show for today!

Priya: That's it for Money Daily. We'll be back tomorrow. Maybe by then, I'll have outsourced my job to my new AI travel agent.

This show is made with AI: the hosts’ voices are synthetic and the scripts are AI-assisted. Every story links to its original source.